TSH RECEPTOR AUTOREGULATION
TSH RECEPTOR AUTOREGULATION
批准号:
10620193
负责人:
TERRY Francis DAVIES
金额:
$0.0万
依托单位国家:
美国
项目类别:
财政年份:
2011
资助国家:
美国
项目状态:
已结题
起止时间:
2011-01-01 至 2024-03-31
关键词:
AccelerationActive SitesAdipocytesAgonistAntibodiesAntigensAutoimmuneBindingBiologyBioluminescenceBody partCRISPR/Cas technologyCell physiologyCellsCharacteristicsCo-ImmunoprecipitationsCytometryDevelopmentDiseaseEnergy TransferEyeFatty acid glycerol estersFibroblastsFluorescenceFluorescence Resonance Energy TransferFundingGTP-Binding ProteinsGraves&apos DiseaseGrowth and Development functionHomeostasisHumanIGF1R geneImmuneImmune responseImmunohistochemistryImmunologic ReceptorsKnockout MiceKnowledgeLearningLife Cycle StagesLigandsLinkMainstreamingMalignant neoplasm of thyroidMass Spectrum AnalysisMembrane MicrodomainsMessenger RNAMolecularMonitorMuscleOperative Surgical ProceduresOsteoblastsOsteoclastsPathway interactionsPatientsPhenotypePhosphorylationPhysiologyPreparationRNA SplicingReceptor GeneReceptor SignalingRoleRouteSignal TransductionSiteSkinSmall Interfering RNASuspensionsSystemTSH receptor antibodyTestingThyroid DiseasesThyroid GlandThyroid HormonesThyrotropin ReceptorTissuesTransactivationVariantWestern BlottingWomanantagonistautoimmune thyroid diseasebonebone cellcomparison controldesigndimerexperienceglycosylationimmunoreactivityinhibitormenmilitary veterannovelprotein activationreceptorreceptor expressionsmall moleculesrc-Family Kinasesthyroid associated ophthalmopathiestraffickingtumor
中文摘要
摘要
甲状腺促甲状腺激素受体(TSHR)是甲状腺激素合成和分泌的主要控制点。
释放以及甲状腺的生长和发育,也表达在各种各样的非
甲状腺组织包括脂肪细胞、成纤维细胞、破骨细胞、成骨细胞和免疫细胞。这个
TSHR是自身免疫性甲状腺疾病,尤其是Graves病的主要抗原。然而,
TSHR调节非甲状腺细胞的机制在很大程度上还不清楚,而且
甲状腺外TSHR的自身免疫作用大多未知。在本意见书中,我们打算
探索由OUR辅助的精选甲状腺外TSHR的详细生物学和免疫作用
丰富的甲状腺细胞TSHR分析经验。我们有三个具体目标:
具体目标1-探索分子表征、翻译后加工
以及TSHR在甲状腺外人类细胞中的受体路径。
具体目标2-检查异源受体相互作用和
研究TSHR的反式激活。
特定目标3-分析甲状腺外TSHR的免疫反应性
虽然甲状腺TSHR已经得到了广泛的探索,但对甲状腺外TSHR的认识
TSHR的表达揭示了我们知识中的巨大差距。已生成的信息
这表明这些位点是活跃的,并调节受体生物学和疾病,正如我们对
骨细胞和TSHR-KO小鼠已经证明。然而,人们担心这样的TSHR是
免疫抑制仍未被发现。我们对受体的认识存在很大差距
这些额外的甲状腺组织的生物学存在,我们的研究将开始澄清其中的一些
问题。
英文摘要
SUMMARY
The thyroidal TSH receptor (TSHR) is the major control point for thyroid hormone synthesis and
release as well as thyroid growth and development and is also expressed in a wide variety of non-
thyroid tissues including adipocytes, fibroblasts, osteoclasts, osteoblasts and immune cells. The
TSHR is a major antigen in autoimmune thyroid disease, especially Graves' disease. However,
the mechanisms by which the TSHR modulates non-thyroidal cells is largely unclear and the
autoimmune role of extra-thyroidal TSHRs mostly unknown. In this submission, we intend to
explore the detailed biology and immune role of selected extra-thyroidal TSHRs aided by our
extensive experience with TSHR analysis in thyroid cells. We have 3 specific aims:
Specific Aim 1- Explore the molecular characterization, posttranslational processing
and receptor routing of TSHRs in extra-thyroidal human cells.
Specific Aim 2- Examine the promiscuity of heterologous receptor interactions and
study TSHR transactivation.
Specific Aim 3- Analyze the immunoreactivity of extra thyroidal TSHRs
Although the thyroidal TSHR has been extensively explored, the recognition of extra-thyroidal
TSHR expression has revealed a large gap in our knowledge. Information already generated
suggests that such sites are active and modulate receptor biology and disease as our studies on
bone cells and TSHR-KO mice have illustrated. However, concerns that such TSHRs are
immunologically suppressed remain unexplored. Large gaps in our knowledge of the receptor
biology of these extra thyroidal tissues exist and our studies will begin to clarify some of these
questions.
期刊论文(8)
专著(0)
科研奖励(0)
会议论文
Implications of an Improved Model of the TSH Receptor Transmembrane Domain (TSHR-TMD-TRIO).
TSH 受体跨膜域 (TSHR-TMD-TRIO) 改进模型的意义。
DOI:
10.1210/endocr/bqab051
发表时间:
2021
期刊:
Endocrinology
影响因子:
4.8
作者:
[Mezei,Mihaly, Latif,Rauf, Das,Bhaskar, Davies,TerryF]
通讯作者:
Davies,TerryF
DOI:
10.7554/elife.81415
发表时间:
2022-10-28
期刊:
eLife
影响因子:
7.7
作者:
[Mezei M, Latif R, Davies TF]
通讯作者:
Davies TF
Modeling TSH Receptor Dimerization at the Transmembrane Domain.
跨膜域的 TSH 受体二聚化建模。
DOI:
10.1210/endocr/bqac168
发表时间:
2022
期刊:
Endocrinology
影响因子:
4.8
作者:
[Mezei,Mihaly, Latif,Rauf, Davies,TerryF]
通讯作者:
Davies,TerryF
Thyrotropin Receptor, Thyrotropin and Mechanisms of Bone Loss
-
批准号:10182095
-
项目类别:
-
资助金额:$40.78万
-
财政年份:2017
-
负责人:TERRY Francis DAVIES
-
依托单位:
Thyrotropin Receptor, Thyrotropin and Mechanisms of Bone Loss
-
批准号:9317142
-
项目类别:
-
资助金额:$62.7万
-
财政年份:2017
-
负责人:TERRY Francis DAVIES
-
依托单位:
Thyrotropin Receptor, Thyrotropin and Mechanisms of Bone Loss
-
批准号:9906208
-
项目类别:
-
资助金额:$59.07万
-
财政年份:2017
-
负责人:TERRY Francis DAVIES
-
依托单位:
TSH RECEPTOR AUTOREGULATION
-
批准号:9887511
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2011
-
负责人:TERRY Francis DAVIES
-
依托单位:
TSH RECEPTOR AUTOREGULATION
-
批准号:10456019
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2011
-
负责人:TERRY Francis DAVIES
-
依托单位:
TSH RECEPTOR MULTIMERIZATION
-
批准号:7931718
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2011
-
负责人:TERRY Francis DAVIES
-
依托单位:
TSH RECEPTOR MULTIMERIZATION
-
批准号:8597377
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2011
-
负责人:TERRY Francis DAVIES
-
依托单位:
TSH RECEPTOR AUTOREGULATION
-
批准号:9037499
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2011
-
负责人:TERRY Francis DAVIES
-
依托单位:
TSH RECEPTOR AUTOREGULATION
-
批准号:9280772
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2011
-
负责人:TERRY Francis DAVIES
-
依托单位:
TSH RECEPTOR MULTIMERIZATION
-
批准号:8397573
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2011
-
负责人:TERRY Francis DAVIES
-
依托单位:
TSH RECEPTOR MULTIMERIZATION
-
批准号:8245568
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2011
-
负责人:TERRY Francis DAVIES
-
依托单位:
Monoclonal Thyroid Stimulating Antibodies
-
批准号:7998502
-
项目类别:
-
资助金额:$4.5万
-
财政年份:2010
-
负责人:TERRY Francis DAVIES
-
依托单位:
TSH and Bone
-
批准号:7990134
-
项目类别:
-
资助金额:$26.5万
-
财政年份:2009
-
负责人:TERRY Francis DAVIES
-
依托单位:
TSH and Bone
-
批准号:8225311
-
项目类别:
-
资助金额:$48.63万
-
财政年份:2009
-
负责人:TERRY Francis DAVIES
-
依托单位:
TSH and Bone
-
批准号:7579661
-
项目类别:
-
资助金额:$57.94万
-
财政年份:2009
-
负责人:TERRY Francis DAVIES
-
依托单位:
TSH and Bone
-
批准号:8386921
-
项目类别:
-
资助金额:$46.8万
-
财政年份:2009
-
负责人:TERRY Francis DAVIES
-
依托单位:
TSH and Bone
-
批准号:7754649
-
项目类别:
-
资助金额:$53.77万
-
财政年份:2009
-
负责人:TERRY Francis DAVIES
-
依托单位:
TSH and Bone
-
批准号:8013006
-
项目类别:
-
资助金额:$48.56万
-
财政年份:2009
-
负责人:TERRY Francis DAVIES
-
依托单位:
Monoclonal Thyroid Stimulating Antibodies
-
批准号:7571621
-
项目类别:
-
资助金额:$33.07万
-
财政年份:2006
-
负责人:TERRY Francis DAVIES
-
依托单位:
Monoclonal Thyroid Stimulating Antibodies
-
批准号:7094010
-
项目类别:
-
资助金额:$34.75万
-
财政年份:2006
-
负责人:TERRY Francis DAVIES
-
依托单位:
海外基金